United States Alpha-glucosidase Inhibitors Sales Market Report 2021

August 2016 | 105 pages | ID: U39A9BE7709EN
QYResearch

Abstracts

This report studies sales (consumption) of Alpha-glucosidase Inhibitors in USA market, focuses on the top players, with sales, price, revenue and market share for each player in USA, covering

• Sanofi
• Bayer
• Takeda Pharmaceuticals
• Eli Lilly
• Merck & Co.
• Novo Nordisk
• Bristol-Myers Squibb
• Pfizer
• AstraZeneca
• GlaxoSmithKline
• Boehringer Ingelheim

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Type 1
• Type 2
• Type 3

Split by applications, this report focuses on sales, market share and growth rate of Alpha-glucosidase Inhibitors in each application, can be divided into

• Application 1
• Application 2
• Application 3

Contents

1 ALPHA-GLUCOSIDASE INHIBITORS OVERVIEW

1.1 Product Overview and Scope of Alpha-glucosidase Inhibitors
1.2 Classification of Alpha-glucosidase Inhibitors
  1.2.1 Type
  1.2.2 Type
  1.2.3 Type
1.3 Applications of Alpha-glucosidase Inhibitors
1.4 USA Market Size (Value and Volume) of Alpha-glucosidase Inhibitors (2011-2021)
  1.4.1 USA Alpha-glucosidase Inhibitors Sales, Revenue and Price (2011-2021)
  1.4.2 USA Alpha-glucosidase Inhibitors Sales and Growth Rate (2011-2021)
  1.4.3 USA Alpha-glucosidase Inhibitors Revenue and Growth Rate (2011-2021)

2 USA ALPHA-GLUCOSIDASE INHIBITORS COMPETITION BY MANUFACTURERS

2.1 USA Alpha-glucosidase Inhibitors Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 USA Alpha-glucosidase Inhibitors Revenue and Share by Manufactures (2015-2016)

3 USA ALPHA-GLUCOSIDASE INHIBITORS (VOLUME AND VALUE) BY TYPE

3.1 USA Alpha-glucosidase Inhibitors Sales and Market Share by Type (2011-2021)
3.2 USA Alpha-glucosidase Inhibitors Revenue and Market Share by Type (2011 and 2021)

4 USA ALPHA-GLUCOSIDASE INHIBITORS (VOLUME) BY APPLICATION

5 USA ALPHA-GLUCOSIDASE INHIBITORS MANUFACTURERS ANALYSIS

5.1 Sanofi
  5.1.1 Company Basic Information, Manufacturing Base and Competitors
  5.1.2 Alpha-glucosidase Inhibitors Product Type and Technology
    5.1.2.1 Type
    5.1.2.2 Type
  5.1.3 Alpha-glucosidase Inhibitors Sales, Revenue, Price of Sanofi (2015 and 2016)
5.2 Bayer
  5.2.1 Company Basic Information,Manufacturing Base and Competitors
  5.2.2 Medicine Product Type and Technology
    5.2.2.1 Type
    5.2.2.2 Type
  5.2.3 Medicine Sales, Revenue, Price of Bayer (2015 and 2016)
5.3 Takeda Pharmaceuticals
  5.3.1 Company Basic Information,Manufacturing Base and Competitors
  5.3.2 Takeda Pharmaceuticals Product Type and Technology
    5.3.2.1 Type
    5.3.2.2 Type
  5.3.3 Takeda Pharmaceuticals Sales, Revenue, Price of Takeda Pharmaceuticals (2015 and 2016)
5.4 Eli Lilly
  5.4.1 Company Basic Information,Manufacturing Base and Competitors
  5.4.2 AstraZeneca Product Type and Technology
    5.4.2.1 Type
    5.4.2.2 Type
  5.4.3 Eli Lilly Sales, Revenue, Price of Eli Lilly (2015 and 2016)
5.5 Merck & Co.
  5.5.1 Company Basic Information,Manufacturing Base and Competitors
  5.5.2 Merck & Co. Product Type and Technology
    5.5.2.1 Type
    5.5.2.2 Type
  5.5.3 Merck & Co. Sales, Revenue, Price of Merck & Co. (2015 and 2016)
5.6 Novo Nordisk
  5.6.1 Company Basic Information,Manufacturing Base and Competitors
  5.6.2 Novo Nordisk Product Type and Technology
    5.6.2.1 Type
    5.6.2.2 Type
  5.6.3 Novo Nordisk Sales, Revenue, Price of Novo Nordisk (2015 and 2016)
5.7 Bristol-Myers Squibb
  5.7.1 Company Basic Information,Manufacturing Base and Competitors
  5.7.2 Bristol-Myers Squibb Product Type and Technology
    5.7.2.1 Type
    5.7.2.2 Type
  5.7.3 Bristol-Myers Squibb Sales, Revenue, Price of Bristol-Myers Squibb (2015 and 2016)
5.8 Pfizer
  5.8.1 Company Basic Information,Manufacturing Base and Competitors
  5.8.2 Pfizer Product Type and Technology
    5.8.2.1 Type
    5.8.2.2 Type
  5.8.3 Pfizer Sales, Revenue, Price of Pfizer (2015 and 2016)
5.9 AstraZeneca
  5.9.1 Company Basic Information,Manufacturing Base and Competitors
  5.9.2 AstraZeneca Product Type and Technology
    5.9.2.1 Type
    5.9.2.2 Type
  5.9.3 AstraZeneca Sales, Revenue, Price of AstraZeneca (2015 and 2016)
5.10 GlaxoSmithKline
  5.10.1 Company Basic Information,Manufacturing Base and Competitors
  5.10.2 GlaxoSmithKline Product Type and Technology
    5.10.2.1 Type
    5.10.2.2 Type
  5.10.3 GlaxoSmithKline Sales, Revenue, Price of GlaxoSmithKline (2015 and 2016)
5.11 Boehringer Ingelheim

6 ALPHA-GLUCOSIDASE INHIBITORS TECHNOLOGY AND DEVELOPMENT TREND

6.1 Alpha-glucosidase Inhibitors Technology Analysis
6.2 Alpha-glucosidase Inhibitors Technology Development Trend

7 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Alpha-glucosidase Inhibitors
Table Classification of Alpha-glucosidase Inhibitors
Figure USA Sales Market Share of Alpha-glucosidase Inhibitors by Types in 2015
Table Applications of Alpha-glucosidase Inhibitors
Figure USA Sales Market Share of Alpha-glucosidase Inhibitors by Applications in 2015
Table USA Alpha-glucosidase Inhibitors Sales, Revenue and Price (2011-2021)
Figure USA Alpha-glucosidase Inhibitors Sales and Growth Rate (2011-2021)
Figure USA Alpha-glucosidase Inhibitors Revenue and Growth Rate (2011-2021)
Table USA AAA Sales of Key Manufacturers (2015 and 2016)
Table USA AAA Sales Share by Manufacturers (2015 and 2016)
Figure 2015 AAA Sales Share by Manufacturers
Figure 2016 AAA Sales Share by Manufacturers
Table USA AAA Revenue by Manufacturers (2015 and 2016)
Table USA AAA Revenue Share by Manufacturers (2015 and 2016)
Table 2015 USA AAA Revenue Share by Manufacturers
Table 2016 USA AAA Revenue Share by Manufacturers
Table USA AAA Sales and Market Share by Type (2011-2021)
Table USA AAA Sales Share by Type (2011-2021)
Figure Sales Market Share of AAA by Type (2011-2021)
Figure USA AAA Sales Growth Rate by Type (2011-2021)
Table USA AAA Revenue and Market Share by Type (2011-2021)
Table USA AAA Revenue Share by Type (2011-2021)
Figure Revenue Market Share of AAA by Type (2011-2021)
Figure USA AAA Revenue Growth Rate by Type (2011-2021)
Table USA AAA Sales and Market Share by Application (2011-2021)
Table USA AAA Sales Share by Application (2011-2021)
Figure Sales Market Share of AAA by Application (2011-2021)
Figure USA AAA Sales Growth Rate by Application (2011-2021)
Table Sanofi Basic Information List
Table Alpha-glucosidase Inhibitors Sales, Revenue, Price of Sanofi (2015 and 2016)
Table Bayer Basic Information List
Table Alpha-glucosidase Inhibitors Sales, Revenue, Price of Bayer (2015 and 2016)
Table Takeda Pharmaceuticals Basic Information List
Table Alpha-glucosidase Inhibitors Sales, Revenue, Price of Takeda Pharmaceuticals (2015 and 2016)
Table Eli Lilly Basic Information List
Table Alpha-glucosidase Inhibitors Sales, Revenue, Price of Eli Lilly (2015 and 2016)
Table Merck & Co. Basic Information List
Table Alpha-glucosidase Inhibitors Sales, Revenue, Price of Merck & Co. (2015 and 2016)
Table Novo Nordisk Basic Information List
Table Alpha-glucosidase Inhibitors Sales, Revenue, Price of Novo Nordisk (2015 and 2016)
Table Bristol-Myers Squibb Basic Information List
Table Alpha-glucosidase Inhibitors Sales, Revenue, Price of Bristol-Myers Squibb (2015 and 2016)
Table Pfizer Basic Information List
Table Alpha-glucosidase Inhibitors Sales, Revenue, Price of Pfizer (2015 and 2016)
Table AstraZeneca Basic Information List
Table Alpha-glucosidase Inhibitors Sales, Revenue, Price of AstraZeneca (2015 and 2016)
Table GlaxoSmithKline Basic Information List
Table Alpha-glucosidase Inhibitors Sales, Revenue, Price of GlaxoSmithKline (2015 and 2016)
Table Boehringer Ingelheim Basic Information List
Table Alpha-glucosidase Inhibitors Sales, Revenue, Price of Boehringer Ingelheim (2015 and 2016)